Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Revitalizing antibiotic discovery and development through in vitro modelling of in-patient conditions

4 Jan 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Pharmaceutical and Antibiotic Environmental Impacts

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38177300
DOI: 10.1038/s41564-023-01566-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Revitalizing antibiotic discovery and development through in vitro modelling of in-patient conditionsPMID 38177300Read ↗

Antibiotic Development and the Evolving Role of Pharmacodynamics - As Good as It Gets?Semantic proximity Read ↗

Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to HumansSemantic proximity Read ↗

MiGut: a scalable <i>in vitro</i> platform for simulating the human gut microbiome – development, validation, and simulation of antibiotic induced dysbiosisSemantic proximity Read ↗

Simultaneous in vitro simulation of multiple antimicrobial agents with different elimination half-lives in a pre-clinical infection modelSemantic proximity Read ↗

The Dawn of a New Era in Drug Discovery? Drug Screening and the Increasing Biological Complexity of Testing Models.Semantic proximity Read ↗

Introduction to biological complexity as a missing link in drug discovery.Semantic proximity Read ↗

Drug repurposing through nonhypothesis driven phenotypic screeningSemantic proximity Read ↗

[PK/PD of antimicrobials].Semantic proximity Read ↗

Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal modelsSemantic proximity Read ↗

Transitioning pharmacoperones to therapeutic use: In vivo proof-of-principle and design of high throughput screensSemantic proximity Read ↗

Drug repositioning in response to COVID-19 and other challenging diseasesSemantic proximity Read ↗

DRUG REPURPOSING-Overcoming the translational hurdles to clinical use.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.